⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVPH News
Reviva Pharmaceuticals Holdings, Inc. Common Stock
Schizophrenia Market to Gain Momentum During the Forecast Period (2026-2036), with Growing Pipeline of Novel and Long-Acting Therapies | DelveInsight
prnewswire.com
TEVA
RVPH
NBIX
ALKS
VNDA
JNJ
Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH
Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
RVPH
Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH
Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
globenewswire.com
RVPH
Form 8-K
sec.gov
RVPH